Two years after percutaneous coronary intervention, people at risk of a cardiac event had better outcomes with clopidogrel ...

For decades, the clinical approach to coronary artery disease has been centred on the acute effects of coronary occlusion and ...

Patients who have a stent implanted to open a blocked coronary artery face dual risks of developing blood clots and of having excessive bleeding in the months following the procedure. While routine ...

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's ...

Denis Keane was discovered on the floor by nursing staff after an unwitnessed fall at Tallaght University Hospital ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...

The University of Medicine and Health Sciences, (UMHS), a small, mission-driven medical school with a commitment to student ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

A step forward in de-escalating treatment The evolution of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has been shaped by the continuous challenge of balancing ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...

For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more ...

Christian T. Ruff, MD, MPH, of Brigham and Women's Faulkner Hospital, discusses new data comparing abelacimab with ...